The First Affiliated Hospital of Guangdong Pharmaceutical University | China
Prof. Liu Wei is a distinguished medical educator and Director at the First Affiliated Hospital of Guangdong Pharmaceutical University, recognized nationally and provincially for his leadership in clinical medical education, standardized residency training, and medical education management. With an extensive academic portfolio, he has authored over 16 research papers, including 6 SCI-indexed publications, with an h-index of 12 and more than 662 citations, reflecting his influence in medical education and clinical research. He has successfully led more than 10 national and provincial research projects and served as deputy chief editor of two textbooks under China’s 13th Five-Year Plan. His expertise spans clinical teaching innovation, curriculum ideological integration, digital transformation in education, and medical simulation. Prof. Liu has earned numerous accolades, including the National Medical Education Best Practice Award, the Ministry of Education Smart Education Excellent Case Award, the Guangdong Province Graduate Teaching Achievement Special Award, and the AI Teaching Innovation Award. As a first-class course leader at both national and provincial levels, his work has been highlighted by authoritative platforms such as China Education Online and the Ministry of Education’s Medical Education Research Center. Overall, Prof. Liu Wei stands out as a leading figure advancing excellence, innovation, and reform in China’s medical education system.
Profile : Scopus
Featured Publications
“Using virtual reality simulation to ensure laparoscopic camera navigation skills of new surgical assistants – a validation study”
“The integrated teaching practice of medical cloud dictionary development and project-based learning”
“Ultrasound-activated erythrocyte membrane-camouflaged Pt (II) layered double hydroxide enhances PD-1 inhibitor efficacy in triple-negative breast cancer through cGAS-STING pathway-mediated immunogenic cell death”
“Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment”
“Mesenchymal stem cells in knee osteoarthritis treatment: A systematic review and meta-analysis”
“MiR-27a-3p Targeting GSK3β Promotes Triple Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway”